Journal of Clinical Immunology

, Volume 23, Issue 4, pp 291–296 | Cite as

Association of −1087 IL10 and −308 TNFA Gene Polymorphisms with Serological Markers of Coeliac Disease

  • M. Hahn-Zoric
  • A. M. Hytönen
  • L. Å. Hanson
  • L. Å. Nilsson
  • L. Padyukov


Coeliac disease (CD) is known to have a strong genetic background. We analyzed the association between serological markers of CD and the −1087 IL10 and −308 TNFA gene polymorphisms in Swedish patients. A higher frequency of the TNF2 allele was present in the patients compared with the controls (p <0.0001). The frequency of the AA genotype of the IL10 gene in the patients was unexpectedly higher in comparison with the controls (p <0.05). The levels of IgA anti-endomysium and antitissue transglutaminase antibodies were associated with IL10 but not with TNFA genotype. The patients with the AA or GG −1087 IL10 genotypes had significantly lower levels of antibodies in comparison with those with the AG genotype (p <0.05 to p <0.0005). However, when divided according to potential level of IL-10 production, the group of potentially high IL-10 producers among the CD patients demonstrated significantly lower levels of antitissue transglutaminase antibodies compared to potentially low IL-10 producers (p = 0.01). Our results show a relationship between the levels of IgA antibodies involved in CD with the IL10 genotypes. This suggests a possible involvement of IL-10 in the development of the disease.

antibodies IL-10 TNF cytokine gene polymorphism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sollid LM: Coeliac disease: Dissecting a complex inflammatory disorder. Nat Rev Immunol 2:647–655, 2002Google Scholar
  2. 2.
    Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P: Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37:766–776, 1995Google Scholar
  3. 3.
    McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D: TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 26:2113–2118, 1996Google Scholar
  4. 4.
    Knight JC, Kwiatkowski D: Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Phys 111:290–298, 1999Google Scholar
  5. 5.
    Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1–8, 1997Google Scholar
  6. 6.
    Koppelman B, Neefjes JJ, de Vries JE, de Waal Malefyt R: Interleukin-10 down-regulates MHC class II alpha/beta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861–871, 1997Google Scholar
  7. 7.
    Ascher H, Hahn-Zoric M, Hanson LA, Kilander AF, Nilsson LA, Tlaskalova H: Value of serologic markers for clinical diagnosis and population studies of coeliac disease. Scand J Gastroenterol 31:61–67, 1996Google Scholar
  8. 8.
    Mäki M: Coeliac disease and autoimmunity due to unmasking of cryptic epitopes? Lancet 348:1046–1047, 1996Google Scholar
  9. 9.
    Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei M: Production of anti-endomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 348:1065–1067, 1996Google Scholar
  10. 10.
    Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797–801, 1997Google Scholar
  11. 11.
    Kilander AF, Dotevall G, Fallstrom SP, Gillberg RE, Nilsson LA, Tarkowski A: Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol 18:377–383, 1983Google Scholar
  12. 12.
    Emanuel SL, Pestka S: Amplification of specific gene products from human serum. Genet Anal Tech Appl 10:144–146, 1993Google Scholar
  13. 13.
    Padyukov L, Hahn-Zoric M, Blomqvist SR, Ulanova M, Welch SG, Feeney AJ, Lau YL, Hanson LA: Distribution of human kappa locus IGKV2–29 and IGKV2D-29 alleles in Swedish Caucasians and Hong Kong Chinese. Immunogenetics 53:22–30, 2001Google Scholar
  14. 14.
    Grodzinsky E, Jansson G, Skogh T, Stenhammar L, Falth-Magnusson K: Anti-endomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: A clinical study to develop a practical routine. Acta Paediatr 84:294–298, 1995Google Scholar
  15. 15.
    Padyukov L, Hahn-Zoric M, Lau YL, Hanson LA: Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians. Genes Immunol 2:280–283, 2001Google Scholar
  16. 16.
    Beckett CG, Dell'Olio D, Kontakou M, Przemioslo RT, Rosen-Bronson S, Ciclitira PJ: Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease. Gut 39:818–823, 1996Google Scholar
  17. 17.
    Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, Jahnsen J, Scott H, Brandtzaeg P: Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115:551–563, 1998Google Scholar
  18. 18.
    Ishizuka K, Sugimura K, Homma T, Matsuzawa J, Mochizuki T, Kobayashi M, Suzuki K, Otsuka K, Tashiro K, Yamaguchi O, Asakura H: Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis. Digestion 63:22–27, 2001Google Scholar
  19. 19.
    Ploski R, Ek J, Thorsby E, Sollid LM: On the HLA-DQ (alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: A possible gene dosage effect of DQB1*0201. Tissue Antigens 41:173–177, 1993Google Scholar
  20. 20.
    Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C: A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: Implications for autoimmunity. Hum Immunol 62:705–713, 2001Google Scholar
  21. 21.
    de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA: Celiac disease and TNF promoter polymorphisms. Hum Immunol 61:513–517, 2000Google Scholar
  22. 22.
    Kroeger KM, Carville KS, Abraham LJ: The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391–399, 1997Google Scholar
  23. 23.
    Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV: Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314–2317, 1997Google Scholar
  24. 24.
    Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P, Hutchinson IV, Ollier WE: IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145, 1998Google Scholar
  25. 25.
    Rischmueller M, Limaye V, Lester S, Downie-Doyle S, Pile K, Bardy P, Gordon TP: Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. J Rheumatol 27:2945–2946, 2000Google Scholar
  26. 26.
    Cook MC, Korner H, Riminton DS, Lemckert FA, Hasbold J, Amesbury M, Hodgkin PD, Cyster JG, Sedgwick JD, Basten A: Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med 188:1503–1510, 1998Google Scholar
  27. 27.
    Campbell IK, O'Donnell K, Lawlor KE, Wicks IP: Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest 107:1519–1527, 2001Google Scholar

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  • M. Hahn-Zoric
    • 1
  • A. M. Hytönen
    • 1
  • L. Å. Hanson
    • 1
  • L. Å. Nilsson
    • 2
  • L. Padyukov
    • 1
    • 3
  1. 1.Department of Clinical ImmunologyUniversity of GöteborgGöteborgSweden
  2. 2.Department of Medical Microbiology and ImmunologyUniversity of GöteborgGöteborgSweden
  3. 3.Immunoassay DepartmentMechnikov Research Institute for Vaccines & SeraMoscowRussia

Personalised recommendations